Industry City—owned by Belvedere Capital, Jamestown, and Angelo Gordon & Co.— announced that Aanika Biosciences, a synthetic biology company focused on food security is growing its footprint through the signing of a new lease at the 16-building, six-million-square-foot creative campus.
Aanika Biosciences expanded its lab space from 900 to 2,500 s/f as the company continues to provide food and agricultural companies with enhanced food security measures.
“There are a lot of biotech companies who have graduated from their incubator programs, received funding, and want to create a home for themselves— but they’re hesitant to sign long term leases when they don’t fully know their trajectory,” said Kathe Chase, Director of Leasing at Industry City. “That’s where we come in—we’re able to connect them with other tenants, quickly build out their spaces, and, in the case of Aanika Biosciences, grow them into bigger spaces when the time comes to scale, without breaking their leases.”
“When our company needed a larger space to support our rapidly expanding R&D and biomanufacturing operations, having room to grow right where we were situated was paramount,” said Vishaal Bhuyan, CEO at Aanika Biosciences. “The built-in culture, great amenities and community of support among Industry City businesses are unique and have helped us recruit the best people as we continue to add members to our team.”
The expansion of Aanika Biosciences at IC will allow the company to not only grow their footprint from a square footage and operations standpoint, but simultaneously grow their employee base. Aanika Biosciences looks to add 10-15 new employees to its team.
Industry City was represented by Elizabeth Henry in the Aanika Biosciences transaction. Aanika Biosciences was not represented.